| Patents for C07C 233 - Carboxylic acid amides (28,881) |
|---|
| 04/23/2003 | CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/23/2003 | CN1413187A Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |
| 04/23/2003 | CN1106445C Method for cleaning dirt fabric using cleaning compositions with glycerol amides |
| 04/23/2003 | CN1106380C New synthetic catechol derivatives, method for production and use thereof |
| 04/23/2003 | CN1106379C 2-propyl valeramide and 2-propyl valeramide derivative and medical use as anticonvulsants |
| 04/23/2003 | CN1106371C Liquid crystal compounds having perfluoroether terminal portions |
| 04/22/2003 | US6552229 Method for preparing 4-nitroso-substituted aromatic amine |
| 04/22/2003 | US6552207 Process for the preparation of amphoglycinates from vegetable oils and butters and the use thereof |
| 04/22/2003 | US6552206 Isolated n-benzyl-9-oxo-16-hydroxy-octadeca-10,12,14-triene amide; treating and preventing cancer and sexual dysfunction |
| 04/22/2003 | US6552205 C10 OXO and hydrido taxane derivatives and pharmaceutical compositions containing them |
| 04/22/2003 | US6552187 Cyclization condensation of arylmalonic acid diamides or arylmalonic acid monoamides with hydrazine derivatives forming substituted 3-hydroxy-4-aryl-5-oxopyrazolines; high yield and purity |
| 04/22/2003 | US6552088 Biphenyl derivatives |
| 04/17/2003 | WO2003031456A2 Ligands for asymmetric reactions |
| 04/17/2003 | WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 04/17/2003 | WO2003007875A3 Compounds with analgesic, antipyretic and/or anti-inflammatory activity |
| 04/17/2003 | WO1998003518A3 New bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity |
| 04/17/2003 | US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents |
| 04/17/2003 | US20030073851 Arylphenyl-substituted cyclic ketoenols |
| 04/17/2003 | US20030073731 Alkylation therapy; anticancer agent |
| 04/17/2003 | US20030073671 Side effect reduction; hormone replacement therapy |
| 04/17/2003 | US20030070241 Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 04/17/2003 | CA2458430A1 Ligands for asymmetric reactions |
| 04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/16/2003 | EP1301497A1 Colchinol derivatives as vascular damaging agents |
| 04/16/2003 | EP1301470A1 Degradable crosslinkers, compositions therefrom, and methods of their preparation and use |
| 04/16/2003 | EP1301458A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 04/16/2003 | EP1109819B1 Ferrocene-based diphosphonites for asymmetrical catalysis |
| 04/16/2003 | EP1100332B1 Herbicidal phenoxypropionic acid n-alkyl-n-2-fluorophenyl amide compounds |
| 04/16/2003 | EP1040095B1 Cyclohexene carboxylates as neuraminidase inhibitors |
| 04/16/2003 | EP0968173B1 Process for the preparation of iodinated contrast agents and intermediates therefor |
| 04/16/2003 | CN1105558C 2,2-dichloroalkane carboxylic acids, process for preparing same, medicament containing same and use for treating insulin resistance |
| 04/15/2003 | US6548522 N-substituted 2,2-diphenylacetamide or N-substituted 2-phenyl-2-pyridinylacetamide |
| 04/10/2003 | WO2003030151A2 Lubricant for magnetic recording medium and use thereof |
| 04/10/2003 | WO2003029219A1 Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives |
| 04/10/2003 | WO2003029187A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003029169A2 Hydroxypropylamines |
| 04/10/2003 | WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 04/10/2003 | US20030069457 Preparation and use of non-chrome catalysts for Cu/Cr catalyst applications |
| 04/10/2003 | US20030069312 Nitromethyl ketones, process for preparing them and compositions containing them |
| 04/10/2003 | US20030069267 Modulators of protein tyrosine phosphatases (PTPases) |
| 04/10/2003 | US20030069261 Therapy for eating disorders, sexual disorders, psychological disorders |
| 04/10/2003 | US20030068388 N-benzyl-16(R,S)-hydroxy-9-oxo-10E,12E,14E-octadecatrieneamide isolated from Lepidium plant material, useful for treating and preventing cancer and sexual disorder |
| 04/10/2003 | CA2462851A1 Hydroxypropylamines |
| 04/09/2003 | EP1299401A1 Chiral ligands for asymmetric catalysis |
| 04/09/2003 | EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 04/09/2003 | EP1299352A2 Compounds to treat alzheimer's disease |
| 04/09/2003 | EP1299349A2 Compounds to treat alzheimer's disease |
| 04/09/2003 | EP1299346A2 Process for forming an amide bond |
| 04/09/2003 | EP1163194B1 Selective nitrogen functionalisation of organic compounds |
| 04/09/2003 | EP1080096B1 Novel furylphosphines and organometallic complexes containing them |
| 04/09/2003 | EP1001766B1 Compounds for the treatment of ccr5-mediated diseases |
| 04/08/2003 | US6545176 Apparatus and process for the high yield production of methyl methacrylate or methacrylic acid |
| 04/08/2003 | US6545174 Contaning diarylbutadienes |
| 04/08/2003 | US6545108 Catalysts containing N-pyrrolyl substituted nitrogen donors |
| 04/08/2003 | US6545053 Aminoethoxyfluorene derivatives are beta-3 adrenaline receptor agonists and are useful as drugs for the treatment and prevention of diabetes, obesity, hyperlipemia, etc. |
| 04/08/2003 | US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/08/2003 | US6545018 Oxamic acids and derivatives as thyroid receptor ligands |
| 04/03/2003 | WO2003027068A2 Substituted amines for the treatment of neurological disorders |
| 04/03/2003 | WO2003027059A1 Acid amide derivatives, process for producing these, and pest control agent containing these |
| 04/03/2003 | WO2003027058A1 Sphingolipids |
| 04/03/2003 | WO2003027057A1 Method for preparing of cationic surfactants and fabric softener composition using the same |
| 04/03/2003 | WO2003026415A2 Insecticidal diamides |
| 04/03/2003 | US20030065219 Cyclization of an alcohol containing urea compound |
| 04/03/2003 | US20030065211 Method for producing n-butyryl-4-amino-3-methyl-methyl benzoate and the novel compound n-(4-bromine-2-methylphenyl)-butanamide |
| 04/03/2003 | US20030065200 Taxanes having T-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | US20030065181 Novel chiral phosphorus ligands and the use thereof in the production of optically active products |
| 04/03/2003 | US20030065039 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones |
| 04/03/2003 | US20030065014 Substance for inducing apoptosis |
| 04/03/2003 | US20030061968 Paving compositions and methods for their use |
| 04/03/2003 | CA2461801A1 Sphingolipids |
| 04/03/2003 | CA2461603A1 Substituted amines for the treatment of neurological disorders |
| 04/02/2003 | EP1298136A2 Chiral monophosphorus compounds |
| 04/02/2003 | EP1298123A1 Purified polyoxypropylene fatty acid isopropanolamide surfactants, production thereof and detergent compositions containing the surfactants |
| 04/02/2003 | EP1297333A2 Ingestibles possessing intrinsic color change |
| 04/02/2003 | EP1296994A1 Ferrocenyl diphosphines and their use |
| 04/02/2003 | EP1296938A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 04/02/2003 | EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/02/2003 | EP1296931A2 Polyamine analogues as cytotoxic agents |
| 04/02/2003 | EP1296929A2 Modified forms of pharmacologically active agents and uses therefor |
| 04/02/2003 | EP1296687A2 Treatment of male sexual dysfunction |
| 04/02/2003 | EP0934923B1 Optically active erythro-3-amino-2-hydroxybutyric esters and process for preparing said esters |
| 04/02/2003 | EP0873295B1 Dimer-selective rxr modulators and methods for their use |
| 04/02/2003 | EP0850231B1 Process for preparing a 2-chloro-5-chloromethyl-thiazole compound |
| 04/02/2003 | EP0681574B1 C7 Taxane derivatives and pharmaceutical compositions containing them |
| 04/02/2003 | CN1407968A Adamantane derivatives |
| 04/02/2003 | CN1407024A Preparation of 1-amino-4-hydroxy anthraquino |
| 04/02/2003 | CN1406928A Industrial production of capsaicin with seed and skin of red hot pepper as material |
| 04/02/2003 | CN1104409C Aminotetralone derivatives and process for producing same |
| 04/01/2003 | US6541656 Reacting an alpha, beta unsaturated carboxylic acid ester with a heterocyclic oxygen nitrogen, or sulfur compound |
| 04/01/2003 | US6541654 Such as 5(S)-N-acetyl-2(R)-methyl-4-keto-6-phenyl hexanoate; useful alone or as intermediates in preparation of antipodes of ketomethylene pseudopeptides useful as antibiotics, antibiotic enhancers, or enzyme inhibitors |
| 04/01/2003 | US6541521 Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 04/01/2003 | US6541473 Resorcinol derivatives |
| 04/01/2003 | CA2405623A1 Chiral monophosphorus compounds |
| 03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
| 03/27/2003 | WO2003024439A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 03/27/2003 | WO2002081078A3 Solid phase synthesis supports and methods |
| 03/27/2003 | WO2002030915A3 Aryl-indane compounds for use as inhibitors of p-glycoprotein mediated transport |
| 03/27/2003 | WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents |